Cargando…

Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017

BACKGROUND: The benefits of antiretroviral therapy (ART) underpin the recommendations for the early detection of HIV infection and ART initiation. Late initiation (LI) of antiretroviral therapy compromises the benefits of ART both individually and in the community. Indeed, it promotes the transmissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngongo, Nadine Mayasi, Darcis, Gilles, Nanituna, Hippolyte Situakibanza, Mambimbi, Marcel Mbula, Maes, Nathalie, Mashi, Murielle Longokolo, Bepouka Izizag, Ben, Moutschen, Michel, Lepira Bompeka, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570501/
https://www.ncbi.nlm.nih.gov/pubmed/34739506
http://dx.doi.org/10.1371/journal.pone.0259073
_version_ 1784594854585565184
author Ngongo, Nadine Mayasi
Darcis, Gilles
Nanituna, Hippolyte Situakibanza
Mambimbi, Marcel Mbula
Maes, Nathalie
Mashi, Murielle Longokolo
Bepouka Izizag, Ben
Moutschen, Michel
Lepira Bompeka, François
author_facet Ngongo, Nadine Mayasi
Darcis, Gilles
Nanituna, Hippolyte Situakibanza
Mambimbi, Marcel Mbula
Maes, Nathalie
Mashi, Murielle Longokolo
Bepouka Izizag, Ben
Moutschen, Michel
Lepira Bompeka, François
author_sort Ngongo, Nadine Mayasi
collection PubMed
description BACKGROUND: The benefits of antiretroviral therapy (ART) underpin the recommendations for the early detection of HIV infection and ART initiation. Late initiation (LI) of antiretroviral therapy compromises the benefits of ART both individually and in the community. Indeed, it promotes the transmission of infection and higher HIV-related morbidity and mortality with complicated and costly clinical management. This study aims to analyze the evolutionary trends in the median CD4 count, the median time to initiation of ART, the proportion of patients with advanced HIV disease at the initiation of ART between 2006 and 2017 and their factors. METHODS AND FINDINGS: HIV-positive adults (≥ 16 years old) who initiated ART between January 1, 2006 and December 31, 2017 in 25 HIV care facilities in Kinshasa, the capital of DRC, were eligible. The data were processed anonymously. LI is defined as CD4≤350 cells/μl and/or WHO clinical stage III or IV and advanced HIV disease (AHD), as CD4≤200 cells/μl and/or stage WHO clinic IV. Factors associated with advanced HIV disease at ART initiation were analyzed, irrespective of year of enrollment in HIV care, using logistic regression models. A total of 7278 patients (55% admitted after 2013) with an average age of 40.9 years were included. The majority were composed of women (71%), highly educated women (68%) and married or widowed women (61%). The median CD4 was 213 cells/μl, 76.7% of patients had CD4≤350 cells/μl, 46.1% had CD4≤200 cells/μl, and 59% of patients were at WHO clinical stages 3 or 4. Men had a more advanced clinical stage (p <0.046) and immunosuppression (p<0.0007) than women. Overall, 70% of patients started ART late, and 25% had AHD. Between 2006 and 2017, the median CD4 count increased from 190 cells/μl to 331 cells/μl (p<0.0001), and the proportions of patients with LI and AHD decreased from 76% to 47% (p< 0.0001) and from 18.7% to 8.9% (p<0.0001), respectively. The median time to initiation of ART after screening for HIV infection decreased from 40 to zero months (p<0.0001), and the proportion of time to initiation of ART in the month increased from 39 to 93.3% (p<0.0001) in the same period. The probability of LI of ART was higher in married couples (OR: 1.7; 95% CI: 1.3–2.3) (p<0.0007) and lower in patients with higher education (OR: 0.74; 95% CI: 0.64–0.86) (p<0.0001). CONCLUSION: Despite increasingly rapid treatment, the proportions of LI and AHD remain high. New approaches to early detection, the first condition for early ART and a key to ending the HIV epidemic, such as home and work HIV testing, HIV self-testing and screening at the point of service, must be implemented.
format Online
Article
Text
id pubmed-8570501
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85705012021-11-06 Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017 Ngongo, Nadine Mayasi Darcis, Gilles Nanituna, Hippolyte Situakibanza Mambimbi, Marcel Mbula Maes, Nathalie Mashi, Murielle Longokolo Bepouka Izizag, Ben Moutschen, Michel Lepira Bompeka, François PLoS One Research Article BACKGROUND: The benefits of antiretroviral therapy (ART) underpin the recommendations for the early detection of HIV infection and ART initiation. Late initiation (LI) of antiretroviral therapy compromises the benefits of ART both individually and in the community. Indeed, it promotes the transmission of infection and higher HIV-related morbidity and mortality with complicated and costly clinical management. This study aims to analyze the evolutionary trends in the median CD4 count, the median time to initiation of ART, the proportion of patients with advanced HIV disease at the initiation of ART between 2006 and 2017 and their factors. METHODS AND FINDINGS: HIV-positive adults (≥ 16 years old) who initiated ART between January 1, 2006 and December 31, 2017 in 25 HIV care facilities in Kinshasa, the capital of DRC, were eligible. The data were processed anonymously. LI is defined as CD4≤350 cells/μl and/or WHO clinical stage III or IV and advanced HIV disease (AHD), as CD4≤200 cells/μl and/or stage WHO clinic IV. Factors associated with advanced HIV disease at ART initiation were analyzed, irrespective of year of enrollment in HIV care, using logistic regression models. A total of 7278 patients (55% admitted after 2013) with an average age of 40.9 years were included. The majority were composed of women (71%), highly educated women (68%) and married or widowed women (61%). The median CD4 was 213 cells/μl, 76.7% of patients had CD4≤350 cells/μl, 46.1% had CD4≤200 cells/μl, and 59% of patients were at WHO clinical stages 3 or 4. Men had a more advanced clinical stage (p <0.046) and immunosuppression (p<0.0007) than women. Overall, 70% of patients started ART late, and 25% had AHD. Between 2006 and 2017, the median CD4 count increased from 190 cells/μl to 331 cells/μl (p<0.0001), and the proportions of patients with LI and AHD decreased from 76% to 47% (p< 0.0001) and from 18.7% to 8.9% (p<0.0001), respectively. The median time to initiation of ART after screening for HIV infection decreased from 40 to zero months (p<0.0001), and the proportion of time to initiation of ART in the month increased from 39 to 93.3% (p<0.0001) in the same period. The probability of LI of ART was higher in married couples (OR: 1.7; 95% CI: 1.3–2.3) (p<0.0007) and lower in patients with higher education (OR: 0.74; 95% CI: 0.64–0.86) (p<0.0001). CONCLUSION: Despite increasingly rapid treatment, the proportions of LI and AHD remain high. New approaches to early detection, the first condition for early ART and a key to ending the HIV epidemic, such as home and work HIV testing, HIV self-testing and screening at the point of service, must be implemented. Public Library of Science 2021-11-05 /pmc/articles/PMC8570501/ /pubmed/34739506 http://dx.doi.org/10.1371/journal.pone.0259073 Text en © 2021 Ngongo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ngongo, Nadine Mayasi
Darcis, Gilles
Nanituna, Hippolyte Situakibanza
Mambimbi, Marcel Mbula
Maes, Nathalie
Mashi, Murielle Longokolo
Bepouka Izizag, Ben
Moutschen, Michel
Lepira Bompeka, François
Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
title Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
title_full Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
title_fullStr Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
title_full_unstemmed Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
title_short Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
title_sort longitudinal analysis of sociodemographic, clinical and therapeutic factors of hiv-infected individuals in kinshasa at antiretroviral therapy initiation during 2006-2017
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570501/
https://www.ncbi.nlm.nih.gov/pubmed/34739506
http://dx.doi.org/10.1371/journal.pone.0259073
work_keys_str_mv AT ngongonadinemayasi longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT darcisgilles longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT nanitunahippolytesituakibanza longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT mambimbimarcelmbula longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT maesnathalie longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT mashimuriellelongokolo longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT bepoukaizizagben longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT moutschenmichel longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017
AT lepirabompekafrancois longitudinalanalysisofsociodemographicclinicalandtherapeuticfactorsofhivinfectedindividualsinkinshasaatantiretroviraltherapyinitiationduring20062017